History of Cocaine: From Miracle Medicine to Controlled Substance

Most patients I see who are struggling with cocaine use disorder have no idea the drug was once handed out in pharmacies, prescribed by psychiatrists, and stirred into wine sold across Europe. When I explain that Sigmund Freud was personally addicted and spent years promoting it as a cure for morphine dependence, something shifts. Addiction stops feeling like a personal failure and starts looking like what it is: a predictable neurological consequence of a drug that has been underestimated, commercially exploited, and misunderstood for over a century.

Ancient Origins: Coca Leaves in the Andes

The coca plant, Erythroxylum coca, has grown on the eastern slopes of the Andes for somewhere between 8,000 and 10,000 years. Archaeological evidence from northern Peru places coca leaf chewing at around 6,000 BCE. The plant itself is unremarkable in appearance: a two-metre shrub with oval green leaves, containing roughly 0.5 to 1% cocaine by dry weight.

The mechanism of chewing coca leaves is specific. Leaves are not swallowed. They are tucked into the cheek alongside an alkaline activator, typically llicta (a paste made from plant ash or quinoa) or cal (calcium hydroxide from burned seashells). The alkaline environment raises the pH in the mouth, which converts the cocaine salts in the leaf into free-base cocaine, allowing mucosal absorption. The effect is mild stimulation, appetite suppression, and altitude sickness relief.

This was genuinely useful medicine in the Andes. At 3,000 to 4,000 metres above sea level, hypoxia is a real physiological problem. Coca leaf chewing increases red blood cell production and improves oxygen utilisation. The Inca empire understood this empirically and structured their labour system around it.

Cocaine and the Inca Empire

At its territorial peak between 1438 and 1533 CE, the Inca empire stretched 4,000 kilometres from southern Colombia to central Chile, encompassing roughly 12 million people. Coca was not simply a recreational substance. It was a state-controlled commodity that functioned as currency, wages, and ritual offering simultaneously.

The Inca emperor declared coca sacred. Only nobility, priests, and those performing state labour were permitted full access. Runners who maintained the empire’s 24,000-kilometre road network carried coca pouches to sustain endurance at altitude. Priests chewed coca during religious ceremonies. Soldiers received coca rations before campaigns.

This structural integration of coca into Inca governance meant that when Spanish conquistadors arrived in 1532, they encountered a population with deep, multigenerational familiarity with the plant. The Spanish initially attempted to suppress coca use, condemning it as a pagan practice. That changed within decades when they discovered it made indigenous workers more productive in the silver mines of Potosí. By the mid-1500s, Spanish colonial authorities were taxing the coca trade and distributing leaves to mine workers as part of their wage.

European Discovery and the First Cocaine Extractions

Coca leaves reached Europe sporadically from the 1500s onward, but the active compound remained unknown. The leaves degraded during long sea voyages, losing much of their potency by the time they arrived in European scientific institutions.

In 1860, German chemist Albert Niemann isolated the pure alkaloid from coca leaves at the University of Göttingen. He named it cocaine. His doctoral thesis noted that the compound produced a numbing sensation on the tongue. He died the following year at 26, before the pharmacological significance of his finding was understood.

It was Carl Koller, a Viennese ophthalmologist, who in 1884 demonstrated cocaine’s use as a local anaesthetic for eye surgery. Before this, eye operations required general anaesthesia or physical restraint because the eye cannot be numbed by conventional methods. Cocaine’s ability to block voltage-gated sodium channels in nerve fibres, preventing the generation of action potentials, made it the first effective local anaesthetic in medical history. Koller presented his findings at a conference in Heidelberg in September 1884, and the news spread through European and American medical circles within weeks.

The Freud and Halsted Era: When Cocaine Was a Miracle Drug

Two men, on opposite sides of the Atlantic, would come to define cocaine’s moment of medical triumph and its equally swift catastrophe.

Sigmund Freud, then a 28-year-old neurologist in Vienna with no established reputation, read about cocaine in the spring of 1884. He obtained a supply from the pharmaceutical company Merck and began experimenting on himself. By July 1884 he had published “Über Coca,” a paper describing cocaine’s ability to relieve fatigue, elevate mood, suppress hunger, and potentially treat morphine addiction and depression. The paper was enthusiastic to the point of advocacy. Freud recommended oral doses of 0.05 to 0.1 grams for fatigue. He prescribed it to his fiancée, his sisters, and his colleagues.

Freud’s neuroscience was not wrong. Cocaine inhibits the dopamine transporter (DAT), the serotonin transporter (SERT), and the norepinephrine transporter simultaneously, flooding the synaptic cleft with monoamines. The euphoria is real. The energy is real. The problem, which Freud did not yet understand, is that the brain adapts by downregulating dopamine receptor density, creating dependence within weeks of regular use. Freud continued using cocaine, in diminishing returns, for approximately 12 years.

William Halsted, then a celebrated New York surgeon, encountered cocaine in October 1884 following Koller’s discovery. He immediately grasped the surgical potential and began conducting experiments in nerve block anaesthesia, injecting cocaine directly into nerve trunks to numb entire limbs for surgery. The results were revolutionary. He developed the first systematic brachial plexus nerve block and the first inferior dental nerve block still taught in surgical training.

The problem: Halsted used himself as the primary experimental subject. By early 1885, he was addicted. His behaviour became erratic. He disappeared from the operating theatre for weeks. He was eventually committed to a private sanitarium in Providence, Rhode Island, twice. He was never fully free of cocaine, and some accounts suggest he managed the addiction in part through morphine substitution for the rest of his career. He died in 1922.

Cocaine in Commercial Products: Vin Mariani to Coca-Cola

While Freud and Halsted were conducting their experiments, a Corsican chemist named Angelo Mariani had already been selling cocaine-infused wine across Europe since 1863. Vin Mariani combined Bordeaux wine with coca leaf extract. Each standard glass delivered roughly 7 milligrams of cocaine, enhanced by the fact that combining cocaine with ethanol in the stomach produces cocaethylene, a pharmacologically active compound with its own stimulant and cardiotoxic properties. You can read more about that specific interaction in detail on the cocaine and alcohol page.

Vin Mariani collected endorsements from Pope Leo XIII, Queen Victoria, President William McKinley, Thomas Edison, and Jules Verne. Mariani published an illustrated promotional book featuring their testimonials.

In 1886, American pharmacist John Pemberton created a similar product: a syrup combining coca leaf extract and kola nut caffeine, initially sold as a patent medicine for headaches and fatigue. He named it Coca-Cola. The drink contained approximately 9 milligrams of cocaine per serving until 1903, when cocaine was removed from the formula following growing public concern, leaving decocainised coca leaf extract as a flavouring agent, which the formula still uses today.

The Rise of the Hypodermic Needle and Cocaine Injection

The invention of the hypodermic syringe in the 1850s changed cocaine’s risk profile dramatically. Chewing coca leaves produces slow, moderate absorption through the buccal mucosa. Intravenous injection produces peak plasma concentrations within 30 to 60 seconds, delivering a far more intense dopamine surge.

By the 1880s and 1890s, cocaine injection was common in medical settings and increasingly common outside them. The speed and intensity of the dopamine spike correlated directly with addiction potential. This is a principle that applies consistently across substances: the faster a drug reaches peak brain concentration, the more reinforcing the experience and the faster dependence develops. The transition from oral to injectable cocaine was, neurobiologically, a different drug problem.

Early Regulation: The Harrison Narcotics Tax Act and Global Controls

Public and political pressure against cocaine grew through the 1890s and 1900s. Newspaper coverage in the United States connected cocaine use with racial minorities and violent crime in a nakedly racist framing that has been well-documented by historians. The science of addiction was not driving the regulatory response. Social panic was.

The Harrison Narcotics Tax Act of 1914 was the first major federal legislation in the United States to restrict cocaine distribution. Despite its name, it covered cocaine as well as opiates. The Act required registration and taxation of anyone distributing cocaine, effectively criminalising its non-medical use. By 1922, the Narcotic Drugs Import and Export Act restricted cocaine to medical and scientific use only.

Internationally, the 1912 Hague Opium Convention had already established the framework for international drug control, with cocaine explicitly included. This laid the groundwork for the 1961 United Nations Single Convention on Narcotic Drugs, which placed cocaine in Schedule I, alongside heroin, as substances with high abuse potential and limited accepted medical use under international law.

In the United States, the Controlled Substances Act of 1970 placed cocaine in Schedule II: high abuse potential, but with recognised medical use as a topical local anaesthetic in ENT and ophthalmological surgery. That classification remains current.

The Crack Cocaine Crisis of the 1980s

Powder cocaine was expensive through the 1970s. Crack cocaine, which appeared in US cities around 1984 to 1985, changed that. Crack is produced by combining cocaine hydrochloride with baking soda and water, then heating the mixture until the cocaine free-base precipitates. The resulting solid is smoked, not snorted. If you want to understand the pharmacological and social differences between these two forms in more depth, the differences between crack and powder cocaine are significant and clinically relevant.

Smoking crack delivers cocaine to the brain in approximately 8 to 10 seconds via pulmonary absorption, producing a more intense but shorter-lived effect than intranasal powder cocaine. The shorter duration drives more frequent use and more rapid development of dependence. Crack was cheaper per unit dose, making it accessible in lower-income communities where powder cocaine had been primarily a middle and upper-class drug.

The US government’s response, particularly the Anti-Drug Abuse Act of 1986, introduced a 100:1 sentencing disparity between crack and powder cocaine, requiring the same mandatory minimum prison sentence for 5 grams of crack as for 500 grams of powder cocaine. This disparity, widely criticised as racially discriminatory, was reduced to 18:1 by the Fair Sentencing Act of 2010.

What Cocaine Actually Does to the Brain: The Neuroscience Behind the History

The history makes more sense once you understand the mechanism. Cocaine is a monoamine reuptake inhibitor. It binds to the dopamine transporter (DAT), the serotonin transporter (SERT), and the norepinephrine transporter (NET), blocking each of them. Normally, after a neuron fires and releases dopamine into the synaptic cleft, the DAT protein pumps the dopamine back into the neuron. Cocaine physically blocks that pump.

The result is that dopamine accumulates in the synapse, continuing to stimulate the postsynaptic dopamine receptors, primarily D1 and D2 receptors in the nucleus accumbens, the brain’s primary reward structure. The subjective experience is intense euphoria, confidence, and energy. The physiological experience is vasoconstriction, tachycardia, hypertension, and elevated body temperature.

With repeated use, the brain adapts. Dopamine D2 receptor density decreases. The baseline dopamine system, now calibrated to expect cocaine-level stimulation, produces less response to natural rewards like food, sex, and social interaction. This is the neurological basis of anhedonia in cocaine withdrawal, and it is the same mechanism that was destroying Freud and Halsted in 1885, even though neither of them had the vocabulary to describe it. The detailed effects of this process on brain structure and function are covered in the article on cocaine’s effects on the brain.

Cocaine in Modern Medicine: What It Is Still Used For

This is a point most historical articles skip. Cocaine still has legitimate medical use. It remains a Schedule II substance in the United States precisely because it is the only local anaesthetic with both sodium channel blocking and vasoconstrictive properties in a single agent. ENT surgeons use 4% to 10% topical cocaine solution for nasal surgery and endoscopy because it simultaneously numbs the mucosa and shrinks blood vessels, reducing bleeding. No other approved single-agent topical anaesthetic does both.

That medical use does not rehabilitate cocaine’s recreational profile. The dose used in surgical settings is tightly controlled, topically applied, and pharmacokinetically nothing like insufflation or injection of street cocaine. But the history is not simply one of a dangerous drug masquerading as medicine. It is a drug with genuine utility at specific doses and routes, and catastrophic risk at others.

Cocaine Today: Global Prevalence and Where the Problem Stands

The United Nations Office on Drugs and Crime (UNODC) estimated in its 2023 World Drug Report that approximately 22 million people used cocaine in the previous year globally, with use concentrated in North America, Western Europe, and South America. The cocaine supply chain runs primarily from Colombia, Peru, and Bolivia, the same Andean region where Erythroxylum coca has grown for millennia.

The drug is not chemically the same product that Halsted injected in 1885. Street cocaine is typically 40 to 70% pure cocaine hydrochloride, cut with levamisole (an animal deworming drug with haematological toxicity), phenacetin (a painkiller withdrawn from the market for carcinogenicity), and various local anaesthetics including lidocaine and benzocaine. These adulterants add their own toxicity to cocaine’s pharmacological risks.

The history of cocaine is partly a history of how consistently addiction was misunderstood, minimised, or attributed to personal weakness rather than recognised as what it is: a neurobiological condition. DSM-5 classifies cocaine use disorder on a spectrum from mild to severe, based on criteria including impaired control, social impairment, risky use, and pharmacological dependence. The pattern we see in clinic most often is not dramatic. It is gradual tolerance, increasing frequency, and a slowly narrowing life. By the time patients come to us, the primary complaint is usually not the cocaine itself. It is the relationships, the work performance, and the inability to feel anything without it.

At Phuket Island Rehab, we treat cocaine use disorder with structured residential programmes that address both the pharmacological withdrawal phase and the longer-term dopamine system dysregulation that drives relapse. If the history of cocaine teaches anything practically useful, it is that the drug has been underestimated by physicians, politicians, and patients for 150 years. Getting proper help is not a sign of weakness. It is the appropriate medical response to a condition with clear neurobiological mechanisms.

Cocaine’s history runs from 8,000-year-old Andean medicine to a global Schedule II controlled substance in under a century of industrialised use. The transition from coca leaf to purified cocaine hydrochloride was not inherently malicious. Niemann, Koller, Halsted, and Freud were working at the frontier of their scientific moment, with no framework for understanding addiction neuroscience because that framework did not yet exist. What cocaine actually does, block dopamine, serotonin, and norepinephrine reuptake simultaneously, produce vasospasm, downregulate D2 receptor density with repeated use, and create a withdrawal state characterised by anhedonia and intense craving, was not understood until decades after it had already destroyed careers and lives at the highest levels of medicine. The legal trajectory, from patent medicine to Harrison Act to Schedule II, followed public panic as much as scientific evidence, and the crack cocaine sentencing disparities of the 1980s showed how drug policy can be driven by race and class as much as pharmacology.

What does not change across that entire arc is the biology. The coca leaf chewer in fifteenth-century Cusco and the person presenting to a clinic in 2024 are both interacting with the same molecular mechanism: dopamine transporter blockade in the nucleus accumbens. The dose, speed, and route of administration determine how severe the consequences become. That is the clinically relevant lesson from the history, and it is the one most historical accounts bury in narrative without making explicit. As John A. Smith of Phuket Island Rehab puts it: “Every patient I have worked with who is struggling with cocaine has been surprised by their own addiction. The drug has been convincing people it is manageable since 1884. That is not a coincidence. That is pharmacology.”

When was cocaine first used by humans?

Coca leaf chewing dates back approximately 8,000 years in the Andean regions of South America, making it one of the oldest documented psychoactive practices in human history. Archaeological evidence from Peru places coca use at around 6,000 BCE. The pure alkaloid cocaine was not isolated until 1860, when German chemist Albert Niemann extracted it at the University of Göttingen.

Why was cocaine once legal and sold in medicines?

Cocaine was legal because, for several decades in the late 19th century, no regulatory framework for controlling psychoactive drugs existed, and addiction was not yet understood as a neurobiological process. Cocaine’s real analgesic, stimulant, and anaesthetic properties made it genuinely useful medically, and commercial interests moved quickly to exploit those properties before the risks were recognised. The Harrison Narcotics Tax Act of 1914 was the first US federal legislation to restrict cocaine distribution.

Did Sigmund Freud really promote cocaine?

Yes. Freud published “Über Coca” in 1884, actively promoting cocaine as a treatment for morphine addiction, depression, and fatigue, and used it himself for approximately 12 years. His personal advocacy contributed to widespread medical enthusiasm for the drug in Europe. He gradually withdrew his endorsement as evidence of addiction and harm accumulated, though he never fully acknowledged the role his promotion played in those outcomes.

What is the difference between coca leaves and cocaine?

Coca leaves contain approximately 0.5 to 1% cocaine by weight and produce a mild stimulant effect through slow buccal absorption. Purified cocaine hydrochloride is roughly 100 times more concentrated and, when injected or insufflated, reaches peak brain concentration dramatically faster, producing a far more intense dopamine surge and a correspondingly higher addiction potential. The route and speed of administration, not just the molecule, determine the risk profile.

When did crack cocaine appear and why was it significant?

Crack cocaine emerged in US cities around 1984 to 1985 and represented a shift in cocaine’s accessibility and risk profile. By processing cocaine hydrochloride into a smokable free-base form, it reduced the per-dose cost significantly while increasing the speed of brain delivery to roughly 8 to 10 seconds via pulmonary absorption. This faster onset made crack more intensely reinforcing and more rapidly addictive than powder cocaine, and the resulting public health crisis drove some of the most controversial drug sentencing legislation in US history.

Is cocaine still used in medicine today?

Yes, cocaine retains Schedule II status in the United States because it remains the only single-agent topical anaesthetic that simultaneously blocks nerve conduction and causes vasoconstriction. ENT surgeons use 4% to 10% topical cocaine solution in nasal and sinus procedures where controlling both pain and bleeding with one agent is clinically advantageous. This medical use involves controlled topical application at doses and under conditions that are pharmacokinetically distinct from recreational use.